Aspira Pathlab & Diagnostics has informed that it attached disclosure in Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. This intimation is in compliance with Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.